724 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled study to evaluate the efficacy and safety of rezpegaldesleukin in adults with severe to very-severe alopecia areata

David Rosmarin, Charles Lynde, Timothy Rodgers et al.|British Journal of Dermatology|2024

Cited by 0